BATS BZX Real-Time Price
As of 12:46pm ET
| -0.88 / -0.24%|
The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 381.00, with a high estimate of 510.00 and a low estimate of 324.00. The median estimate represents a +3.23% increase from the last price of 369.09.
The current consensus among 24 polled investment analysts is to Hold stock in Regeneron Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.